Role of bone gammagraphy in the diagnosis of osteomalacy secondary to tenofovir treatment;Utilidad de la gammagrafía ósea en el diagnóstico de osteomalacia secundaria en un paciente en tratamiento con tenofovir

Revista Espanola de Medicina Nuclear

Volumn 25, Issue 2, 2006, Pages 103-106

  Torres Isidro, M V ^a   Garcia Benayas T ^a   Del Val Gomez Martinez M ^a   Gonzalez Gallardo F ^a   Gambi Pisonero N ^b   Castilla Miguel, S ^b   Gonzalez Lahoz J ^a   Gallego Sanz, D ^c  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^c Instituto Madrileno de la Salud   (Spain)

Author keywords

Bone scan; Fanconi syndrome; HIV; Hypophosphatemia; Tenofovir

Indexed keywords

MEDRONATE TECHNETIUM TC 99M; TENOFOVIR;

ADULT; ARTICLE; BONE PAIN; BONE SCINTISCANNING; CASE REPORT; FANCONI RENOTUBULAR SYNDROME; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; OSTEOMALACIA; PATIENT REFERRAL; SECONDARY HYPERPARATHYROIDISM;

EID: 33646505948     PISSN: 02126982     EISSN: None     Source Type: Journal    
DOI: 10.1157/13086252     Document Type: Article

References (22)

1. Miralles P, Padilla O. Experiencia clínica con tenofovir DF: aspectos de seguridad. Enferm Infecc Microbiol Clin. 2004;3:43-7.
2. Tebas P, Powderly WG, Claxton S, Marin D, Tantisiriwat W, Teitelbaum SL, et al. Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS. 2000;14:F63-7.
3. Birkus G, Hitchcock MJ, Cihlar T. Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors. Antimicrob Agents Chemother. 2002;46:716-72.
4. Piliero PJ, Gianoukakis AG. Ritonavir-associated hyperparathyroidism, osteopenia and bone pain. AIDS. 2002;16:1565-6.
5. Schooley RT, Ruane P, Myers RA, Beall G, Lampiris H, Berger D, et al. Tenofovir DF in antiretroviral-experience patients: results from a 48-week, randomised, double-blind study. AIDS. 2002;16:1257-63.
6. Gallant JE, Parish MA, Keruly JC, Moore RD. Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment. Clin Infect Dis. 2005;40:1194-8.
7. Creput C, Gonzalez-Canali G, Hill G, Piketty C, Kazatchkine M, Nochy D. Renal lesions in HIV-1-positive patient treated with tenofovir. AIDS. 2003;17:935-7.
8. Karras A, Lafourie M, Furco A, Bourgarit A, Droz D, Sereni D, et al. Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome and nephrogenic diabetes insipidus. Clin Infect Dis. 2003;36:1070-3.
9. Lee JC, Marosok RD. Acute tubular necrosis in a patient receiving tenofovir. AIDS. 2003;17:2543-4.
10. Peyriere H, Reynes J, Rouanet I, Daniel N, de Boer CM, Mauboussin JM, et al. Renal tubular dysfunction associated with tenofovir therapy. Report of 7 cases. J Acquir Immune Defic Syndr. 2004;35:269-73.
11. Schaaf B, Aries P, Kramme E, Steinhoff J, Dalhoff K. Acute renal failure associated with tenofovir treatment in a patient with acquired immunodeficiency syndrome. Clin Infect Dis. 2003;37:e41-3.
12. Barrios A, García-Benayas T, Soriano V, González-Lahoz J. Tenofovir-related nephrotoxicity in HIV-infected patients. AIDS. 2004;18:960-2.
13. Day SL, Date H, Bannister A, Hankins M, Fischer M. Serum hypophosphatemia in tenofovir disoproxil fumarate recipients is multifactorial in origin, questioning the utility of its monitoring in clinical practice. J Acquir Inmune Defic Syndr. 2005;38:301-4.
14. Fogelman I, Mckillop JA, Bessent RG, Boyle IT, Turner JG, Greig WR. The role of bone scanning in ostemalacia. J Nucl Med. 1978;19:245.
15. Ahmed M, Almahfouz A, Alarifi A, Nasser T, Alkahtani N, Al Dayel F. Hyperparathyroidism secondary to vitamin D deficiency. Clin Nucl Med. 2003;28:413-5.
16. Kim S, Park CH, Chung YS. Hypophosphatemic osteomalacia demonstrated by Tc-99m MDP bone scan. Clin Nucl Med. 2000;25:337-40.
17. Francis MD, Fogelman I. 99mTc diphosphonate uptake mechanism on bone. En: Ignac Fogelman, editor. Bone scanning in clinical practice. Berlin: Springer-Verlag; 1987. p. 7-17.
18. Fogelman I, Citrin DL, Turner JG, Hay ID, Bessent RG, Boyle IT. Semi-quantitative interpretation of the bone scan in metabolic bone disease. Eur J Nucl Med. 1979;4:287-9.
19. Gomez MV, Gallardo FG, Cobo J, Babe J, Rios M, Valencia E. Osteitis in secondary syphilis. Rev Esp Med Nucl. 2003;22:424-6.
20. Brandemburg VM, Ketteler M, Blum U, Riehl J, Floege J. Skeletal scintigraphy in acquired adult Fanconi Syndrome. Clin Nucl Med. 2002;27:53-4.
21. Pham T, Furno-Steib S, Daumen-Legre V, Acquaviva PC, Lafforgue P. Bilateral symmetric polyarthralgia revealing Fanconi's Syndrome. Joint Bone Spine. 2002;69:209-13.
22. Earle KE, Seneviratne T, Shaker J, Shoback D. Fanconi's syndrome in HIV + adults: report of three cases and literatura review. J Bone Miner Res. 2004;19:714-21.